Jan 20, 2022
JAMA Oncology : Early Readout on Overall Survival of Patients With Melanoma Treated With Immunotherapy
18 minutes
Episodes
Ordered by publication date.
Jan 20, 2022
JAMA Otolaryngology–Head & Neck Surgery : Use of FDG-PET/CT to Predict Immunotherapy Treatment Response in Patients With OCSCC
16 minutes
Jan 19, 2022
JAMA Surgery : Biologic vs Synthetic Mesh for Single-stage Repair of Contaminated Ventral Hernias
26 minutes
Jan 18, 2022
JAMA Neurology : Infarct on Brain Imaging, Subsequent Ischemic Stroke, and Clopidogrel-Aspirin Efficacy
17 minutes
Jan 6, 2022
JAMA Ophthalmology : Incidence and Progression of Myopia in Early Adulthood
10 minutes
Jan 5, 2022
JAMA Dermatology : Patient Impressions and Outcomes Following Clinic to Based Hidradenitis Suppurativa Surgery
24 minutes
Dec 30, 2021
JAMA Otolaryngology–Head & Neck Surgery : Associations of Hearing Loss and Dual Sensory Loss With Mortality
14 minutes
Dec 28, 2021
JAMA Internal Medicine : Analytics-Based Intervention for Reducing Sleep Interruption in Hospitalized Patients
18 minutes
Dec 23, 2021
JAMA Oncology : Atezolizumab Plus Bevacizumab vs Sunitinib in Patients With Previously Untreated Metastatic Renal Cell Carcinoma
22 minutes
Dec 23, 2021
JAMA Oncology : Atezolizumab Plus Bevacizumab vs Sunitinib in Patients With Previously Untreated Metastatic Renal Cell Carcinoma
22 minutes
Dec 23, 2021
JAMA Ophthalmology : Assessing Eye Health and Eye Care Needs Among North American Native Individuals
12 minutes
Dec 23, 2021
JAMA Ophthalmology : Assessing Eye Health and Eye Care Needs Among North American Native Individuals
12 minutes
Dec 23, 2021
JAMA Ophthalmology : Assessing Eye Health and Eye Care Needs Among North American Native Individuals
12 minutes
Dec 23, 2021
JAMA Ophthalmology : Assessing Eye Health and Eye Care Needs Among North American Native Individuals
12 minutes
Dec 20, 2021
JAMA Neurology : Assessment of Erenumab Safety and Efficacy in Migraine With and Without Aura
20 minutes
More related podcasts
Other podcasts in Science & Medicine.